TABLE 1.
Nonsepsis control (n = 2) | Sepsis nonsurvivor (n = 2) | Sepsis survivor (n = 3) | |||||
---|---|---|---|---|---|---|---|
Gender | Male | Female | Male | Female | Male | Female | Female |
Age range | 35-40 | 45-50 | 90-95 | 65-70 | 45-50 | 65-70 | 70-75 |
Sepsis etiology | n/a | n/a | E.coli bacteremia | E.coli bacteremia | |||
APACHEII | n/a | n/a | 18 | 38 | 31 | 41 | 19 |
SOFA | n/a | n/a | 11 | 16 | 11 | 15 | 7 |
Time of death (days post enrollment) | n/a | n/a | <30 | 1 | n/a | n/a | n/a |
Plasma cytokines (ng/mL) | |||||||
Resistin | 22.5 | 36.7 | 202 | 135.9 | 147 | 281 | 92 |
IL-6 | N.D | 0.002 | 30.2 | 142.3 | 133 | 2.48 | 0.31 |
IL-8 | 0.03 | 0.026 | 6.65 | 27.2 | 41.7 | 0.61 | 0.4 |
IL-10 | N.D. | N.D. | 0.13 | 9.71 | 0.52 | 0.15 | 0.39 |
LPS-induced TNFα (ng/mL) | |||||||
TNF-α | 0.656 | 0.979 | 0.45 | 0.0046 | n/a | 0.047 | 0.1 |
Abbreviations: APACHE II, acute physiology and chronic health evaluation II; SOFA, sequential organ failure assessment; N.D., Not detected; n/a, not applicable.